Treace Medical Concepts, Inc.
- Last sale
- Nov 12, 2026 · +6.15%
- Market cap
- $350.74M
- 65.56M shares
- Filings
- 447
Q3 2026+1.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−5.7% FY25 yoy
- $350.74M
- —
- 1.7×
- 5.7×
- -5.29%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $212,690,000 | reported | |
| FY 2024 | 2024-12-31 | $209,357,000 | reported | |
| FY 2023 | 2023-12-31 | $187,118,000 | reported | |
| FY 2022 | 2022-12-31 | $141,838,000 | reported | |
| FY 2021 | 2021-12-31 | $94,419,000 | reported | |
| FY 2020 | 2020-12-31 | $57,365,000 | reported | |
| FY 2019 | 2019-12-31 | $39,416,000 | reported |
Surgical & medical instruments & apparatus
Treace Medical Concepts, Inc. is the 41st largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
PRCTPROCEPT BioRobotics Corp$308.1M37.2%31.0%$1.4BSKINSkinHealth Systems Inc.$300.8M10.0%3.2%$106.2MLMATLemaitre Vascular Inc$249.6M13.5%23.1%$1.9BKIDSOrthopediatrics Corp$236.3M15.4%16.8%$851.7MCERSCerus Corp$233.8M16.1%6.7%$390.8M
TMCITreace Medical Concepts, Inc. (this company)$212.7M1.6%27.7%$350.7M
SIBNSi-Bone, Inc.$200.9M20.2%9.4%$1.1BHTFLHeartflow, Inc.$176.0M39.9%66.3%$4.6BSTIMNeuronetics, Inc.$149.2M99.2%26.1%$166.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Treace Medical Concepts, Inc. · CIK 1630627 · Engraved from SEC EDGAR